Crossmark

Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study

Published Online: 2021-04-09

Published Print: 2021-06

Authors

Tatsuoka, Yoshihisa

Takeshima, Takao

Ozeki, Akichika

Matsumura, Taka
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02959177 at ClinicalTrials.gov

Documents that mention this clinical trial

Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study
https://doi.org/10.1007/S40120-021-00236-5
Funding

Funding for this research was provided by:

Eli Lilly Japan
License Information

Text and Data Mining valid from 2021-04-09

Version of Record valid from 2021-04-09
More Information

Article History

Received: 7 December 2020

Accepted: 19 February 2021

First Online: 9 April 2021

Document is current